An endogenous metabolite nanomedicine restores pulmonary neuroimmune homeostasis in septic lung injury

Septic lung injury is a major cause of mortality in critically ill patients, yet targeted therapies remain lacking. Although current therapeutic efforts have largely focused on controlling macrophage-driven inflammation, septic lung injury is increasingly recognized as more than an inflammatory disorder alone, highlighting disrupted pulmonary neuroimmune regulation as an underappreciated therapeutic dimension. Here, we developed a liposomal nanoplatform co-delivering two endogenous metabolites, 5-hydroxyindoleacetic acid (5-HIAA) and spermine (SPM), termed HSLPs, to achieve coordinated regulation of inflammatory macrophage programs and local tissue homeostasis in septic lung injury. In murine sepsis models, HSLPs improved survival, reduced systemic and pulmonary inflammation, alleviated multi-organ injury, and restored alveolar architecture, barrier function, and sensory nerve integrity within septic lungs. Mechanistically, HSLPs promoted macrophage phenotypic reprogramming in part through aryl hydrocarbon receptor (AhR)-dependent signaling, while simultaneously restoring transient receptor potential vanilloid 1 (TRPV1⁺) sensory nerve structure and engaging a calcitonin gene-related peptide (CGRP)-dependent neuroimmune pathway. Together, these results establish HSLPs as an endogenous metabolite-based nanomedicine that protects against septic lung injury through coupled macrophage reprogramming and pulmonary sensory neuroimmune preservation. This study identifies sensory nerve dysfunction as a therapeutically relevant component of septic lung injury and supports endogenous metabolite-based nanomedicine as a strategy for coordinated immune and neural protection in sepsis.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-17
DOI
https://doi.org/10.1186/s12951-026-05276-3
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

An endogenous metabolite nanomedicine restores pulmonary neuroimmune homeostasis in septic lung injury

Xintong Lu, PANGXiao-bin, Gaofei Wei, Jing Wang et al.
7 links
Journal of Nanobiotechnology
Sepsis Diagnosis and Treatment
article

An endogenous metabolite nanomedicine restores pulmonary neuroimmune homeostasis in septic lung injury

Xintong Lu, PANGXiao-bin, Gaofei Wei, Jing Wang, Yue Chen, Jiayi Shen, Xiaolin Liu, Jiarui Dou, Jiaxin Yan, Xuejing Duan, Le Yang
article en

Abstract

Septic lung injury is a major cause of mortality in critically ill patients, yet targeted therapies remain lacking. Although current therapeutic efforts have largely focused on controlling macrophage-driven inflammation, septic lung injury is increasingly recognized as more than an inflammatory disorder alone, highlighting disrupted pulmonary neuroimmune regulation as an underappreciated therapeutic dimension. Here, we developed a liposomal nanoplatform co-delivering two endogenous metabolites, 5-hydroxyindoleacetic acid (5-HIAA) and spermine (SPM), termed HSLPs, to achieve coordinated regulation of inflammatory macrophage programs and local tissue homeostasis in septic lung injury. In murine sepsis models, HSLPs improved survival, reduced systemic and pulmonary inflammation, alleviated multi-organ injury, and restored alveolar architecture, barrier function, and sensory nerve integrity within septic lungs. Mechanistically, HSLPs promoted macrophage phenotypic reprogramming in part through aryl hydrocarbon receptor (AhR)-dependent signaling, while simultaneously restoring transient receptor potential vanilloid 1 (TRPV1⁺) sensory nerve structure and engaging a calcitonin gene-related peptide (CGRP)-dependent neuroimmune pathway. Together, these results establish HSLPs as an endogenous metabolite-based nanomedicine that protects against septic lung injury through coupled macrophage reprogramming and pulmonary sensory neuroimmune preservation. This study identifies sensory nerve dysfunction as a therapeutically relevant component of septic lung injury and supports endogenous metabolite-based nanomedicine as a strategy for coordinated immune and neural protection in sepsis.

Journal of Nanobiotechnology
Northwestern Polytechnical University (CN), Henan University (CN), Northwest Women's and Children's Hospital (CN), Tang Du Hospital (CN), Air Force Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon